Login / Signup

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.

Karin Due BruunKirstine AmrisHenrik Bjarke VaegterMorten Rune Blichfeldt-EckhardtAnders Holsgaard-LarsenRobin ChristensenPalle Toft
Published in: Trials (2021)
EudraCT 2019-000702-30. Registered on 12 July 2019. ClinicalTrials.gov NCT04270877. Registered on 17 February 2020.
Keyphrases
  • low dose
  • double blind
  • placebo controlled
  • randomized controlled trial
  • open label
  • high dose
  • clinical trial
  • phase iii
  • study protocol